Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

First Quarter 2016 Financial Results

Genmab published its First Quarter 2016 financial results and held an investor conference call on May 10. Click the following links to access the archived call: Click here to listen to the webcast.  Click here to download the slide presentation. Click here to download the financial results.  Click here to download a podcast of the conference call.

Join our teamCareer Opportunities at Genmab

Genmab is seeking new employees to join our teams in Copenhagen and Utrecht. Visit our Careers web pages to explore our current vacancies, learn about our culture and meet some of our team members

Our Technologies Explained

Learn about Genmab’s proprietary cutting edge technologies, the DuoBody® and HexaBody® platforms at our new technology website